Within the context of the COVID-19 crisis, our team focused on speeding up the production process of the TipsHaler-HospitHal® sterilizable inhalation chamber so that its commercialization could be anticipated. Initially planned for the fall 2020, our teams have done their best so that medical staff and patients could benefit as soon as possible from this new efficient, practical and economical inhalation chamber made in France.
Autoclave sterilization up to 134°
This new device is undoubtedly the first inhalation chamber which accepts autoclave with such a hard cycle protocol. This performance complements the proven qualities and effectiveness of the TipsHaler® inhalation chamber.
This inhalation chamber allowing the most severe sterilization conditions, the constraint of the single patient has disappeared. The autoclave between two patients thus becomes possible up to 10 sterilizations.
TipsHaler HospitHal® in the context of the COVID-19 crisis
Nebulization induces a risk of dissemination of the COVID-19 virus through the droplets emitted within the patient’s environment. The inhalation chamber is therefore the best alternative for the administration of inhaled treatments to hospitalized patients. The need for inhalation chambers has logically greatly increased. Due to its multi-patient capacity, the sterilizable TipsHaler-HospitHal® inhalation chamber offers substantial savings to a healthcare system weakened by the current crisis.
The sterilizable TipsHaler-HospitHal® for fragile patients
The TipsHaler-HospitHal® sterilizable inhalation chamber has also been designed for the benefit of fragile patients, including those with cystic fibrosis. It allows patients to protect themselves from infections by sterilizing the inhalation chamber, both in hospitals and on an ambulatory basis.